TrialJournal of diabetes investigation2018

Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial.

Aika Miya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.